Dynavax GmbH

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.rheinbiotech.de

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

1

EMA:1

Drug Approvals

Heplisav B

Authorization Status: Authorised

Approval Date: Feb 18, 2021

EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.